Table 3.
Summary of advantages and disadvantages of assays used for urinary hormone monitoring
| Assay | Hormones tested | Advantages and disadvantages |
|---|---|---|
| Radioimmunoassay (RIA) | E1-3G |
• Excellent correlation between E1-3G and serum E2 (optimal urine dilution of 1:200) [52] • Related hazards and drawbacks of handling radioactive material |
| Chemiluminescence immunoassay (CIA) |
E1-3G PdG |
• Provide the stability and sensitivity to detect E1-3G in urine samples, is not significantly affected by background interference, and can be applied to diluted urine without prior purification, with results obtained within 2.5 h [58] • High correlation between urine CIA and serum RIA findings (Pearson’s correlation coefficient 0.92; P < 0.0001) although discrepancies were observed for 23% of patients due to hormone pulsality in blood rather than the urine samples [47] • Successfully used to monitor urinary PdG in normally menstruating healthy women [64] |
| Enzyme immunoassay |
Estrone E1C PdG |
• Excellent intra-individual correlation between urinary estrone and serum E2, and urinary E1C and serum E2 [60, 62] • Effect of gonadotropins on E2 metabolism may impact ability of urinary E1C to predict serum E2 at higher values [60] • Shown to be accurate a reliable for monitoring of urinary PdG and E1C [62, 63] |
| Fluoroimmunoassay |
E1-3G PdG |
• Validated use for measuring E1-3G and PdG [61] • Correlation between urinary hormone profiles and serum profiles with a 1–2 day delay in urine profiles due to steroid metabolism [45] |